Medexus Pharmaceuticals Inc.

TSX:MDP Rapporto sulle azioni

Cap. di mercato: CA$59.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Medexus Pharmaceuticals Crescita futura

Future criteri di controllo 5/6

Medexus Pharmaceuticals prevede che gli utili e i ricavi cresceranno rispettivamente di 49.6% e 7.9% all'anno. Si prevede che l'EPS crescerà di 43.2% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 29.8% in 3 anni.

Informazioni chiave

49.6%

Tasso di crescita degli utili

43.2%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili66.3%
Tasso di crescita dei ricavi7.8%
Rendimento futuro del capitale proprio29.8%
Copertura analitica

Good

Ultimo aggiornamento21 Aug 2024

Aggiornamenti recenti sulla crescita futura

Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 10
Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Aug 19
There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 10
Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth

Jul 31
Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth

The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Jun 15
The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Apr 25
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Mar 03
Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Jan 06
Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Oct 11
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 11
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Jan 19
Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 22
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Dec 16
Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Aug 21
Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Aug 04
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Previsioni di crescita degli utili e dei ricavi

TSX:MDP - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202711212N/A313
3/31/2026981N/A214
3/31/20251063N/A186
6/30/202410912223N/A
3/31/202411301819N/A
12/31/202311662121N/A
9/30/202311951313N/A
6/30/2023117367N/A
3/31/20231081-2-1N/A
12/31/2022100-11-3-2N/A
9/30/202292-11-3-1N/A
6/30/202282202N/A
3/31/202277-3-9-1N/A
12/31/202174-8-17-1N/A
9/30/202177-20-18-1N/A
6/30/202177-31-21-5N/A
3/31/202180-28-65N/A
12/31/202079-19-10N/A
9/30/202069-911N/A
6/30/202064-711N/A
3/31/202056-5-3-2N/A
12/31/201947-4-10N/A
9/30/201945-3-10N/A
6/30/201936-6-2-1N/A
3/31/201925-5-1-1N/A
12/31/201817-5-3-2N/A
9/30/20189-5-1-1N/A
6/30/20188-2-2-2N/A
3/31/20188-3N/A-3N/A
12/31/20178-3N/A-3N/A
9/30/20177-3N/A-4N/A
6/30/20176-3N/A-4N/A
3/31/20175-1N/A-1N/A
12/31/201641N/A1N/A
9/30/201631N/A1N/A
6/30/201631N/A1N/A
3/31/20163-2N/A-1N/A
12/31/20153-4N/A-3N/A
9/30/20152-4N/A-3N/A
6/30/20152-5N/A-3N/A
3/31/20152-4N/A-4N/A
12/31/20143-4N/A-3N/A
9/30/20143-4N/A-3N/A
6/30/20144-3N/A-3N/A
3/31/20143-3N/A-1N/A
12/31/20134-2N/A-1N/A
9/30/20133-1N/A-1N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di MDP ( 49.6% all'anno) è superiore al tasso di risparmio ( 2.2% ).

Guadagni vs Mercato: Si prevede che gli utili di MDP ( 49.6% all'anno) cresceranno più rapidamente del mercato Canadian ( 14.9% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di MDP cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di MDP ( 7.9% all'anno) crescerà più rapidamente del mercato Canadian ( 6.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di MDP ( 7.9% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di MDP sarà elevato tra 3 anni ( 29.8 %)

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y